This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Klump, B. Articles by Gregor, M. Search for Related Content PubMed PubMed Citation Articles by Klump, B. Articles by Gregor, M.

Promoter Methylation of INK4a/ARF As Detected in Bile-Significance for the Differential Diagnosis in Biliary Disease¹

Department of Internal Medicine I, University Hospital of Tübingen, D-72076 Tübingen [B. K., C-J. H., S. D., K. H., M. G.]; Department of Internal Medicine, St. Hildegardis Hospital Mainz [R. K., M. J.]; Department of Internal Medicine, Hospital Bad Cannstatt [U. S.]; Department of Internal Medicine, Campus Charite Berlin [M. O.]; Department of Internal Medicine, Central Hospital Bremen East [R. P.], Germany

Purpose: There is a need to enhance endobiliary cytotechniques by molecular marker lesions. This is of special significance for patients with primary sclerosing cholangitis, a disease predisposing for the development of cholangiocarcinoma. The INK4a/ADP ribosylation factor (ARF) locus encodes two tumor suppressor genes: p16INK4a and p14ARF. p16INK4a has been shown to be of major significance in cholangiocarcinoma.

Experimental Design: In an effort to evaluate the potential diagnostic role of p16INK4a and p14ARF promoter methylation in biliary disease, endoscopical obtained bile specimens of 71 patients were analyzed (26 choledocholithiasis, 6 with normal results, 23 bile duct carcinoma, 5 gall bladder carcinoma). Eleven patients with primary sclerosing cholangitis were enrolled.

Results: Merely 6% of specimens (2 of 32) obtained from patients without evidence for malignant biliary disease but 53.5% of malignancies (15 of 28) showed p16 promoter methylation (p14: 3 and 46.2%, respectively). The concordance of methylation rates detected in either bile or tissue specimens was high. In primary sclerosing cholangitis, a similar prevalence of methylation was detected as in malignant disease.

Conclusions: This study demonstrates: (a) a high frequency and specificity of INK4a/ARF methylation in malignant biliary disease compared with mere cholangitis; and (b) the capability to detect these alterations reliably in endoscopically obtained bile. Thus, INK4a/ARF’s promoter methylation status represents a candidate marker for the endoscopic diagnosis of biliary disease.